Goals are Clear, Biotargets Identified
As of today (June 14, 2016) the Ministry of Industry and Trade of the Russian Federation will start to accept applications for funding of development of innovative drugs.
A list of biotargets for developments of similar and improved analogs of innovative drugs had been approved a few days before that. The corresponding joint order of the Ministry of Industry and Trade of the Russian Federation and The Ministry of Healthcare of Russia of May 19, 2016 No 1605/308н “On approval of a list of biotargets for development of pharmacotherapeutically similar and improved analogs of innovative drugs” was registered on June 8, 2014 by the Ministry of Justice of the Russian Federation.
Now that the order has been approved, pharma companies have a target for work to create new drugs, It concerns drugs with development reimbursed within the framework of the grant scheme defined by the Governmental Decree No 1503 within the framework of governmental program “Development of pharmaceutical and medical industry in 2013-2020”.